Cargando…
Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy
PURPOSE: The purpose of this study was to investigate the typical symptoms and medical management characteristics of adult patients with refractory chronic cough (RCC) who are referred to speech-language pathology (SLP) for behavioral cough suppression therapy (BCST) in order to estimate cost-effect...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203529/ https://www.ncbi.nlm.nih.gov/pubmed/33821355 http://dx.doi.org/10.1007/s00408-021-00442-w |
_version_ | 1783708185784221696 |
---|---|
author | Slovarp, Laurie J. Jetté, Marie E. Gillespie, Amanda I. Reynolds, Jane E. Barkmeier-Kraemer, Julie M. |
author_facet | Slovarp, Laurie J. Jetté, Marie E. Gillespie, Amanda I. Reynolds, Jane E. Barkmeier-Kraemer, Julie M. |
author_sort | Slovarp, Laurie J. |
collection | PubMed |
description | PURPOSE: The purpose of this study was to investigate the typical symptoms and medical management characteristics of adult patients with refractory chronic cough (RCC) who are referred to speech-language pathology (SLP) for behavioral cough suppression therapy (BCST) in order to estimate cost-effectiveness and efficiency of current practice patterns for this population. METHODS: One hundred sixty-four (164) patients with RCC referred for BCST were surveyed. Patients completed an initial survey at BCST onset related to symptom pattern and prior treatment, including the Leicester Cough Questionnaire (LCQ). Every four to six weeks patients completed follow-up surveys to assess their response to BCST. RESULTS: Mean age was 58 years (83.5% women). The majority of patients reported their cough began two or more years prior to BCST. Approximately half (49%) reported seeing four or more physicians (including primary care physicians) and being prescribed four or more medications (57%) prior to BCST. Medications targeting post-nasal drip (72%), reflux (70%), asthma (56%), and allergies (56%) were most commonly prescribed. BCST resulted in a clinically significant improvement in 70.1% of participants. The mean change in LCQ for those who improved with BCST was 6.61. Over half (58%) reported they were quite satisfied to completely satisfied with their treatment response. The average time from enrollment to study completion was 64 days. CONCLUSION: The results of this study suggest early intervention with BCST may be a cost-effective and efficient option for patients with RCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00408-021-00442-w. |
format | Online Article Text |
id | pubmed-8203529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-82035292021-06-17 Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy Slovarp, Laurie J. Jetté, Marie E. Gillespie, Amanda I. Reynolds, Jane E. Barkmeier-Kraemer, Julie M. Lung COUGH and SPEECH LANGUAGE PATHOLOGY PURPOSE: The purpose of this study was to investigate the typical symptoms and medical management characteristics of adult patients with refractory chronic cough (RCC) who are referred to speech-language pathology (SLP) for behavioral cough suppression therapy (BCST) in order to estimate cost-effectiveness and efficiency of current practice patterns for this population. METHODS: One hundred sixty-four (164) patients with RCC referred for BCST were surveyed. Patients completed an initial survey at BCST onset related to symptom pattern and prior treatment, including the Leicester Cough Questionnaire (LCQ). Every four to six weeks patients completed follow-up surveys to assess their response to BCST. RESULTS: Mean age was 58 years (83.5% women). The majority of patients reported their cough began two or more years prior to BCST. Approximately half (49%) reported seeing four or more physicians (including primary care physicians) and being prescribed four or more medications (57%) prior to BCST. Medications targeting post-nasal drip (72%), reflux (70%), asthma (56%), and allergies (56%) were most commonly prescribed. BCST resulted in a clinically significant improvement in 70.1% of participants. The mean change in LCQ for those who improved with BCST was 6.61. Over half (58%) reported they were quite satisfied to completely satisfied with their treatment response. The average time from enrollment to study completion was 64 days. CONCLUSION: The results of this study suggest early intervention with BCST may be a cost-effective and efficient option for patients with RCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00408-021-00442-w. Springer US 2021-04-05 2021 /pmc/articles/PMC8203529/ /pubmed/33821355 http://dx.doi.org/10.1007/s00408-021-00442-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | COUGH and SPEECH LANGUAGE PATHOLOGY Slovarp, Laurie J. Jetté, Marie E. Gillespie, Amanda I. Reynolds, Jane E. Barkmeier-Kraemer, Julie M. Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy |
title | Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy |
title_full | Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy |
title_fullStr | Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy |
title_full_unstemmed | Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy |
title_short | Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy |
title_sort | evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy |
topic | COUGH and SPEECH LANGUAGE PATHOLOGY |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203529/ https://www.ncbi.nlm.nih.gov/pubmed/33821355 http://dx.doi.org/10.1007/s00408-021-00442-w |
work_keys_str_mv | AT slovarplauriej evaluationandmanagementoutcomesandburdensinpatientswithrefractorychroniccoughreferredforbehavioralcoughsuppressiontherapy AT jettemariee evaluationandmanagementoutcomesandburdensinpatientswithrefractorychroniccoughreferredforbehavioralcoughsuppressiontherapy AT gillespieamandai evaluationandmanagementoutcomesandburdensinpatientswithrefractorychroniccoughreferredforbehavioralcoughsuppressiontherapy AT reynoldsjanee evaluationandmanagementoutcomesandburdensinpatientswithrefractorychroniccoughreferredforbehavioralcoughsuppressiontherapy AT barkmeierkraemerjuliem evaluationandmanagementoutcomesandburdensinpatientswithrefractorychroniccoughreferredforbehavioralcoughsuppressiontherapy |